|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fidler MM, Gupta S, Soerjomataram I,
Ferlay J, Steliarova-Foucher E and Bray F: Cancer incidence and
mortality among young adults aged 20–39 years worldwide in 2012: A
population-based study. Lancet Oncol. 18:1579–1589. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jafri MA, Al-Qahtani MH and Shay JW: Role
of miRNAs in human cancer metastasis: Implications for therapeutic
intervention. Semin Cancer Biol. 44:117–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friedman RC, Farh KH, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu X, Chen X, Zeng K, Xu M, He B, Pan Y,
Sun H, Pan B, Xu X, Xu T, et al: DNA-methylation-mediated silencing
of miR-486-5p promotes colorectal cancer proliferation and
migration through activation of PLAGL2/IGF2/β-catenin signal
pathways. Cell Death Dis. 2018. View Article : Google Scholar
|
|
7
|
Feng L, Jing L, Han J, Wang G and Liu Y,
Zhang X, Wang Y, Wang F, Ma H and Liu Y: MicroRNA 486-3p directly
targets BIK and regulates apoptosis and invasion in colorectal
cancer cells. Onco Targets Ther. 11:8791–8801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han C, Song Y and Lian C: MiR-769 inhibits
colorectal cancer cell proliferation and invasion by targeting
HEY1. Med Sci Monit. 24:9232–9239. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizoguchi A, Takayama A, Arai T, Kawauchi
J and Sudo H: MicroRNA-8073: Tumor suppressor and potential
therapeutic treatment. PLoS One. 13:e02097502018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang X, Lou Y, Wang M, Liu C, Liu Y and
Huang W: miR675 promotes colorectal cancer cell growth dependent on
tumor suppressor DMTF1. Mol Med Rep. 19:1481–1490. 2019.PubMed/NCBI
|
|
11
|
Mazeh H, Mizrahi I, Ilyayev N, Halle D,
Brucher B, Bilchik A, Protic M, Daumer M, Stojadinovic A, Itzhak A
and Nissan A: The diagnostic and prognostic role of microRNA in
colorectal cancer-a comprehensive review. J Cancer. 4:281–295.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
DeCastro AJ, Dunphy KA, Hutchinson J,
Balboni AL, Cherukuri P, Jerry DJ and DiRenzo J: MiR203 mediates
subversion of stem cell properties during mammary epithelial
differentiation via repression of ΔNP63alpha and promotes
mesenchymal-to-epithelial transition. Cell Death Dis. 4:e5142013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu D, Hu Y, Xu W, Yu H, Yang N, Ni S and
Fu R: miR203 inhibits the expression of collagen-related genes and
the proliferation of hepatic stellate cells through a
SMAD3-dependent mechanism. Mol Med Rep. 16:1248–1254. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang M, Shi B, Liu J, He L, Yi G, Zhou L,
Yu G and Zhou X: Downregulation of miR203 induces overexpression of
PIK3CA and predicts poor prognosis of gastric cancer patients. Drug
Des Devel Ther. 9:3607–3616. 2015.PubMed/NCBI
|
|
15
|
Xu D, Wang Q, An Y and Xu L: MiR203
regulates the proliferation, apoptosis and cell cycle progression
of pancreatic cancer cells by targeting Survivin. Mol Med Rep.
8:379–384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng B, Wang B, Fang J, Zhu X, Cao Z, Lin
Q, Zhou L and Sun X: MiRNA-203 suppresses cell proliferation,
migration and invasion in colorectal cancer via targeting of
EIF5A2. Sci Rep. 6:283012016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao Z, Qu Z, Chen Z, Fang Z, Zhou K,
Huang Z, Guo X and Zhang Y: LncRNA HOTAIR is a prognostic biomarker
for the proliferation and chemoresistance of colorectal cancer via
MiR-203a-3p-mediated Wnt/ss-catenin signaling pathway. Cell Physiol
Biochem. 46:1275–1285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu S and Feng P: MiR-203 Determines poor
outcome and suppresses tumor growth by targeting TBK1 in
osteosarcoma. Cell Physiol Biochem. 37:1956–1966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burnside MN, Pyatt RE, Hughes A, Baker PB
and Pierson CR: Complex brain malformations associated with
chromosome 6q27 gain that includes THBS2, which encodes
thrombospondin 2, an astrocyte-derived protein of the extracellular
matrix. Pediatr Dev Pathol. 18:59–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhuo C, Li X, Zhuang H, Tian S, Cui H,
Jiang R, Liu C, Tao R and Lin X: Elevated THBS2, COL1A2, and SPP1
expression levels as predictors of gastric cancer prognosis. Cell
Physiol Biochem. 40:1316–1324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun R, Wu J, Chen Y, Lu M, Zhang S, Lu D
and Li Y: Down regulation of Thrombospondin2 predicts poor
prognosis in patients with gastric cancer. Mol Cancer. 13:2252014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fei W, Chen L, Chen J, Shi Q, Zhang L, Liu
S, Li L, Zheng L and Hu X: RBP4 and THBS2 are serum biomarkers for
diagnosis of colorectal cancer. Oncotarget. 8:92254–92264. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang X, Zhang L, Li W, Sun H, Zhang H and
Lai M: THBS2 is a potential prognostic biomarker in colorectal
cancer. Sci Rep. 6:333662016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Adolph KW, Liska DJ and Bornstein P:
Analysis of the promoter and transcription start sites of the human
thrombospondin 2 gene (THBS2). Gene. 193:5–11. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bornstein P, O'Rourke K, Wikstrom K, Wolf
FW, Katz R, Li P and Dixit VM: A second, expressed thrombospondin
gene (Thbs2) exists in the mouse genome. J Biol Chem.
266:12821–12824. 1991.PubMed/NCBI
|
|
26
|
Ao R, Guan L, Wang Y and Wang JN:
Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell
proliferation, migration, and invasion while promoting apoptosis
through the PI3k-Akt signaling pathway. J Cell Biochem.
119:4420–4434. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang IW, Li CF, Lin VC, He HL, Liang PI,
Wu WJ, Li CC and Huang CN: Prognostic impact of thrombospodin-2
(THBS2) overexpression on patients with urothelial carcinomas of
upper urinary tracts and bladders. J Cancer. 7:1541–1549. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin X, Hu D, Chen G, Shi Y, Zhang H, Wang
X, Guo X, Lu L, Black D, Zheng XW and Luo X: Associations of THBS2
and THBS4 polymorphisms to gastric cancer in a Southeast Chinese
population. Cancer Genet. 209:215–222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsai EA, Gilbert MA, Grochowski CM,
Underkoffler LA, Meng H, Zhang X, Wang MM, Shitaye H, Hankenson KD,
Piccoli D, et al: THBS2 is a candidate modifier of liver disease
severity in alagille syndrome. Cell Mol Gastroenterol Hepatol.
2:663–675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei WF, Zhou CF, Wu XG, He LN, Wu LF, Chen
XJ, Yan RM, Zhong M, Yu YH, Liang L and Wang W: MicroRNA-221-3p, a
TWIST2 target, promotes cervical cancer metastasis by directly
targeting THBS2. Cell Death Dis. 8:32202017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu S, Dong H, Dai H, Liu D and Wang Z:
MicroRNA-216b regulated proliferation and invasion of non-small
cell lung cancer by targeting SOX9. Oncol Lett. 15:10077–10083.
2018.PubMed/NCBI:
|
|
32
|
Zhang Y, Su Y, Zhao Y, Lv G and Luo Y:
MicroRNA720 inhibits pancreatic cancer cell proliferation and
invasion by directly targeting cyclin D1. Mol Med Rep.
16:9256–9262. 2017. View Article : Google Scholar : PubMed/NCBI
|
